Chapstick Total Hydration Moisture Tint Pretty In Pink Stick
FDA Recall NDC 0573-0873
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Chapstick Total Hydration Moisture Tint Pretty In Pink (NDC 0573-0873). A significant event, classified as Class III, was initiated on Apr 20, 2020 by Haleon Us Holdings Llc. The reported reason for this action was: "Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card"
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
Class III Terminated
Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card
Apr 20, 2020
May 20, 2020
360 packages
Recall Profile & Regulatory Data
Event ID
85500
Classification
Class III
Enforcement Status
Terminated
Recalling Firm
Glaxosmithkline Consumer Healthcare Holdings
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide
Termination Date
Oct 26, 2021
Product Description
ChapStick Total Hydration Moisture + Tint + SPF15 Pretty in Pink Net Wt. 0.08 OZ (2.2g) Marketed by: Pfizer, Madison, NJ 07940 USA NDC 0573-0873-08
Batch or Lot Expiration Information
Lot# : 9343AA, 9343BA
Affected Packages Involved in this Recall
0573-0873-08Product
0573-0873-11Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
